Press Resease

Digital Dose Inhaler Market - Global Industry Analysis

Digital Dose Inhaler Market: by Product (Dry Powder Inhalers (DPIs) and Metered Dose Inhalers (MDIs)); by Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Other Applications): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Published Date: 14-Nov-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5058 Status : Published

Description

The report covers forecast and analysis for the digital dose inhaler market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the digital dose inhaler market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the digital dose inhaler market on a global as well as regional level.

According to the report, global demand for digital dose inhaler market was valued at approximately USD 1.46 billion in 2018, and is expected to generate revenue of around USD 3.70 billion by end of 2025, growing at a CAGR of around 14.3% between 2019 and 2025.

Global Digital Dose Inhaler Market

In order to give the users of this report a comprehensive view on the digital dose inhaler market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the digital dose inhaler market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the digital dose inhaler market on global and regional basis.

The study provides a crucial view on the digital dose inhaler by segmenting the market based on product, application, and region. All the segments of digital dose inhaler market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

An inhaler is a medical device that delivers medication into the body via the lungs. These inhalers are also called as allergy spray, pump or puffer. Inhalers are widely used for treatment and medication delivery for respiratory diseases such as chronic obstructive pulmonary disease and asthma. Inhalers reduce medication deposition in throat or mouth and also minimize the need for exact synchronization with actuation of the device. Digital inhalers are equipped with built-in sensors that help in tracking usage of inhalers, dose management and dose compliance.

The demand for digital dose inhaler market is driven by increasing prevalence of chronic respiratory diseases such as asthma, chronic pulmonary obstructive disease (COPD) and related decrease in quality of life of patient. Increasing geriatric population across the world, increasing preference and adoption of digital devices, increasing R&D investment for technological improvement and device miniaturization, growing need to achieve medication compliance, patient care enhancement and dose tracking are other important factors that boost the market growth. However, high cost of digital dose inhalers may limit the market growth over the forecast period. Integration of artificial intelligence for digital dose tracking and compliance is expected to bring new opportunities for major market players operating in the global digital dose inhaler along with growth opportunities in emerging markets.

Based on product, global digital dose inhaler market dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Metered dose inhalers (MDIs) product segment accounted for about two third market share in 2018 due to significant innovations such as automatic PK/PD (pharmacokinetic/pharmacodynamics) modeling, electronic monitoring system with patient feedback and controlled release of formulations. Dry powder inhalers (DPIs) product type segment is expected to witness rapid CAGR over the forecast period.

Based on application, digital dose inhaler market is categorized into asthma, chronic obstructive pulmonary disease (COPD), and other applications. Asthma application segment accounted for largest market share in 2018 whereas chronic obstructive pulmonary disease (COPD) segment will see rapid growth over the forecast period. Rising asthma prevalence across the globe has attributed to the large market share.

North America dominated the global digital dose inhaler market in 2018. Increasing prevalence of chronic respiratory disorders, increasing preference for digital devices, presence of major market players, increasing aging population are factors driving the market in this region. Europe was second largest regional market. Availability of developed infrastructure, increasing awareness and prevalence of respiratory disorders are major factors that boost market growth in this region. Latin America is expected to witness moderate growth over the forecast period. Asia Pacific region will exhibit highest growth for digital dose inhaler market in the coming years. Increasing aging population with high vulnerability to chronic respiratory disorders, growing prevalence of asthma, COPD, increasing healthcare expenditure are factors promoting digital dose inhaler market growth in Asia Pacific. Middle East and Africa will see considerable growth in coming years.

Major players included in the report are Philips Respironics, Teva Pharmaceuticals Industries Ltd., AstraZeneca Plc, Novartis AG, Propeller Health, Opko Health, Inc., Glenmark Pharmaceuticals Ltd., GlaxoSmithKline plc., AptarGroup, Inc., and Cipla, Inc. among others.

The report segment of global digital dose inhaler market as follows:

Global Digital Dose Inhaler Market: By Product

  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)

Global Digital Dose Inhaler Market: By Application

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Other Applications

Global Digital Dose Inhaler Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Digital Dose Inhaler Market, 2016-2025 (USD Million)
    • 2.2. Digital Dose Inhaler Market: Snapshot
  • Chapter 3. Digital Dose Inhaler Market - Industry Analysis
    • 3.1. Digital Dose Inhaler Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By Application
      • 3.6.3. Market attractiveness analysis by Region
  • Chapter 4. Digital Dose Inhaler Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Digital Dose Inhaler Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Digital Dose Inhaler Market - By Product Analysis
    • 5.1. Global Digital Dose Inhaler Market overview: By Product
      • 5.1.1. Global Digital Dose Inhaler Marketshare, By Product,2018 and 2025
    • 5.2. Dry Powder Inhalers (DPIs)
      • 5.2.1. Global Digital Dose Inhaler Market by Dry Powder Inhalers (DPIs), 2016-2025 (USD Million)
    • 5.3. Metered Dose Inhalers (MDIs)
      • 5.3.1. Global Digital Dose Inhaler Market by Metered Dose Inhalers (MDIs), 2016-2025 (USD Million)
  • Chapter 6. Global Digital Dose Inhaler Market -Application Analysis
    • 6.1. Global Digital Dose Inhaler Market overview: By Application
      • 6.1.1. Global Digital Dose Inhaler Market share, By Application, 2018 and 2025
    • 6.2. Chronic Obstructive Pulmonary Disease (COPD)
      • 6.2.1. Global Digital Dose Inhaler Market By Chronic Obstructive Pulmonary Disease (COPD), 2016-2025 (USD Million)
    • 6.3. Asthma
      • 6.3.1. Global Digital Dose Inhaler MarketBy Asthma, 2016-2025 (USD Million)
    • 6.4. Others
      • 6.4.1. Global Digital Dose Inhaler Marketby Other Applications, 2016-2025 (USD Million)
  • Chapter 7. Global Digital Dose Inhaler Market - Regional Analysis
    • 7.1. Global Digital Dose Inhaler Market overview: by Region
      • 7.1.1. Global Digital Dose Inhaler Marketshare, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Digital Dose Inhaler Market, 2016-2025 (USD Million)
      • 7.2.2. North America Digital Dose Inhaler Market revenue, By Product,2016-2025 (USD Million)
      • 7.2.3. North America Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S.Digital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
        • 7.2.4.2. The U.S.Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Digital Dose Inhaler Market revenue, By Product,2016-2025 (USD Million)
        • 7.2.5.2. Rest of North America Digital Dose Inhaler Marketrevenue, By Application, 2016-2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Digital Dose Inhaler Market, 2016-2025 (USD Million)
      • 7.3.2. Europe Digital Dose Inhaler Market revenue, By Product,2016-2025 (USD Million)
      • 7.3.3. Europe Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
      • 7.3.4. UK
        • 7.3.4.1. U.K.Digital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
        • 7.3.4.2. U.K.Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Digital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
        • 7.3.5.2. France Digital Dose Inhaler Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Digital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
        • 7.3.6.2. Germany Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of EuropeDigital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
        • 7.3.7.2. Rest of EuropeDigital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Digital Dose Inhaler Market, 2016-2025 (USD Million)
      • 7.4.2. Asia Pacific Digital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
      • 7.4.3. Asia Pacific Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Digital Dose Inhaler Market revenue, By Product,2016-2025 (USD Million)
        • 7.4.4.2. China Digital Dose Inhaler Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Digital Dose Inhaler Market revenue, By Product,2016-2025 (USD Million)
        • 7.4.5.2. Japan Digital Dose Inhaler Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Digital Dose Inhaler Market revenue, By Product,2016-2025 (USD Million)
        • 7.4.6.2. India Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
      • 7.4.7.1. Rest of Asia Pacific Digital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
      • 7.4.7.2. Rest of Asia Pacific Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Digital Dose Inhaler Market, 2016-2025 (USD Million)
      • 7.5.2. Latin America Digital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
      • 7.5.3. Latin America Digital Dose Inhaler Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Digital Dose Inhaler Marketrevenue, By Product,2016-2025 (USD Million)
        • 7.5.4.2. Brazil Digital Dose Inhaler Marketrevenue, By Application, 2016-2025 (USD Million)
      • 7.5.5. Rest of LatinAmerica
        • 7.5.5.1. Rest of LatinAmerica Digital Dose Inhaler Market revenue, By Product,2016-2025 (USD Million)
        • 7.5.5.2. Rest of LatinAmerica Digital Dose Inhaler Market revenue, By Application, 2016-2025 (USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Digital Dose Inhaler Market, 2016-2025 (USD Million)
      • 7.6.2. The Middle East and Africa Digital Dose Inhaler Market revenue, By Product,2016-2025 (USD Million)
      • 7.6.3. The Middle East and Africa Digital Dose Inhaler Marketrevenue, By Application, 2016-2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Philips Respironics
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Teva Pharmaceuticals Industries Ltd.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. AstraZeneca Plc
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Novartis AG
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Propeller Health
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Opko Health, Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Glenmark Pharmaceuticals Ltd
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. GlaxoSmithKline plc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. AptarGroup, Inc.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Cipla, Inc.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social